News
Hosted on MSN3mon
Retro Biosciences: Looking to Give You Another Decade - MSNRetro Biosciences is an anti-aging biotech that got lots of attention in April of 2022 after receiving $180 million from investors. It’s based in Redwood City, CA.
5monon MSN
Altman previously provided Retro Biosciences’ entire seed round of $180 million. Now, the startup is raising a $1 billion Series A that Altman is joining, The Financial Times reports.
OpenAI says it trained a new AI model called GPT-4b micro with Retro Biosciences, a longevity science startup trying to extend the human lifespan by 10 years, according to the MIT Technology Review.
Sam Altman-backed Retro Biosciences to raise $1bn for project to extend human life - Financial Times
Retro Biosciences is raising a $1bn round to fund the artificial intelligence-powered biotech’s mission to increase human lifespan by a decade, starting by getting its first drug into trials ...
Retro Biosciences, meanwhile, emerged that year with a focus on cellular reprogramming and plasma-inspired therapeutics to add 10 “good” years to your life. Altman reportedly invested $180 ...
Bezos-backed Altos Labs launched in 2022 with the aim of reversing aging by rejuvenating cells. Retro Biosciences, meanwhile, emerged that year with a focus on cellular reprogramming and ...
Retro Biosciences, backed by Sam Altman, is raising $1 billion to extend human lifespan - TechCrunch
Retro Biosciences, which says it plans to launch trials for drugs targeting diseases like Alzheimer’s, recently trained a model with OpenAI to turn regular cells into stem cells.
OpenAI says it trained a new AI model called GPT-4b micro with Retro Biosciences, a longevity science startup trying to extend the human lifespan by 10 years, according to the MIT Technology Review.
OpenAI CEO Sam Altman is doubling down on Retro Biosciences, a biotech startup based in San Francisco that wants humans to live 10 years longer than what it calls a healthy human lifespan. Now ...
Retro Biosciences, a startup that aims to use AI to aid in drug development, is reportedly raising $1 billion to support its research, with investors including OpenAI, which has previously backed ...
OpenAI CEO Sam Altman is doubling down on Retro Biosciences, a biotech startup based in San Francisco that wants humans to live 10 years longer than what it calls a healthy human lifespan. Now, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results